This is a preview of subscription content, log in via an institution to check access.
Notes
European Academy of Dermatology and Venereology
Reference
Celgene International SARL. Oral OTEZLA(R) (apremilast) Data Presented at EADV Show Improved Measures of Health-Related Quality of Life and Work Productivity in Patients with Moderate to Severe Plaque Psoriasis. Media Release : 10 Oct 2014. Available from: URL: http://www.celgene.com
Rights and permissions
About this article
Cite this article
Apremilast ESTEEMed for psoriasis. PharmacoEcon Outcomes News 714, 30 (2014). https://doi.org/10.1007/s40274-014-1651-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1651-z